prednisolone 1mg tablets
strides pharma uk ltd - prednisolone - oral tablet - 1mg
prednisolone 1mg tablets
de pharmaceuticals - prednisolone - oral tablet - 1mg
prednisolone 5mg tablets
wockhardt uk ltd - prednisolone - oral tablet - 5mg
prednisolone 5mg soluble tablets
a a h pharmaceuticals ltd - prednisolone sodium phosphate - soluble tablet - 5mg
prednisolone 5mg soluble tablets
advanz pharma - prednisolone sodium phosphate - soluble tablet - 5mg
prednisolone 5mg tablets
waymade healthcare plc - prednisolone - oral tablet - 5mg
prednisolone 5mg soluble tablets
focus pharmaceuticals ltd - prednisolone sodium phosphate - soluble tablet - 5mg
prednisolone 5mg soluble tablets
pilsco ltd - prednisolone sodium phosphate - soluble tablet - 5mg
methylprednisolone mylan 500 mg
genmedix , israel - methylprednisolone as hemisuccinate - lyophilized powder for injection - methylprednisolone as hemisuccinate 500 mg - methylprednisolone - methylprednisolone mylan is indicated to treat any condition in which iv corticosteroid treatment is required such as: endocrine disorders, rheumatic disorders, collagen diseases, immune complex diseases, dermatologic diseases, allergic states, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, management of neoplastic diseases, edematous states, nervous system disorders and organ transplantation
prednisolone- prednisolone solution
pharmaceutical associates, inc. - prednisolone (unii: 9phq9y1olm) (prednisolone - unii:9phq9y1olm) - solution - 15 mg in 5 ml - prednisolone syrup (prednisolone oral solution usp) is indicated in the following conditions: - endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice: synthetic analogs may be used in conjunction with mineralocorticoids where applicable: in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer - rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post-traumatic osteoarthritis synovitis of osteoarthritis epicondylitis - collagen diseases during an exacer